Literature DB >> 2678042

Staging systems for musculoskeletal neoplasms.

H A Finn1, M A Simon.   

Abstract

In the treatment of musculoskeletal neoplasms, preservation of limb function and prolongation of survival have improved over the past decade. With the current emphasis on limb salvage procedures for local control of tumors, and with the addition of adjunctive therapy, the ability to classify and stage these unusual tumors is important in determining prognosis and treatment. In such classifications, a number of prognostic factors are identified and used to define stages. Three recognized staging systems exist for sarcomas of soft tissues and two for sarcomas of bone; there is one system for benign tumors of bone. The prognostic variables used in assigning stages are common to all of these systems, but the relative significance assigned to these variables differs. Documented improvement in survival and preservation of function suggests that current staging systems are significantly affecting outcome in the management of musculoskeletal tumors.

Entities:  

Mesh:

Year:  1989        PMID: 2678042     DOI: 10.3928/0147-7447-19891001-13

Source DB:  PubMed          Journal:  Orthopedics        ISSN: 0147-7447            Impact factor:   1.390


  2 in total

1.  Pathologic fracture does not influence prognosis in stage IIB osteosarcoma: a case-control study.

Authors:  Dongqing Zuo; Longpo Zheng; Wei Sun; Yingqi Hua; Zhengdong Cai
Journal:  World J Surg Oncol       Date:  2013-06-24       Impact factor: 2.754

2.  Pathological fractures in predicting clinical outcomes for patients with osteosarcoma.

Authors:  Lien-Hsiang Chung; Po-Kuei Wu; Cheng-Fong Chen; Hung-Kai Weng; Tain-Hsiung Chen; Wei-Ming Chen
Journal:  BMC Musculoskelet Disord       Date:  2016-12-28       Impact factor: 2.362

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.